www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Business

Medicine trade tops $100b in 2015

By Wang Wen | China Daily | Updated: 2016-02-08 16:03

China's trade in medicines hit an all-time high of $102 billion last year.

The latest figures from the China Chamber of Commerce for Import and Export of Medicines and Health Products show the value was a 4.73 percent increase on 2014, and this year total export-import volumes are expected to rise again, by 3 to 5 percent.

Xu Ming, the chamber's deputy director, called the overall growth "healthy and stable", adding, however, that the Chinese export market had slowed.

Medicine imports were worth $46.2 billion, up 7.3 percent, while exports grew a slower 2.7 percent to $56.4 billion.

"That import growth indicates the Chinese domestic market has huge potential, as it is now the second-largest globally after the United States," said Xu.

The weaker export figures were largely indicative of an ongoing global economic slowdown, Xu said, and coupled with a weaker yuan, they put China on the back foot as an international medicine supplier.

Exports to the US performed well, even though some other main markets dropped. Volumes to the US grew 7.72 percent compared with the previous year and it is now China's second-largest medicine export market after Europe, where demand dropped 0.22 percent.

Xu remains positive that Chinese companies are making strong headway in their moves to expand trade abroad.

Some have been expanding through investment and merger, which is often a more complicated route than simply selling their products directly.

"It's astonishing how some Chinese companies have performed so well in overseas investments," Xu said.

One of the sector's most significant developments in 2015 was by a consortium led by Shanghai Fosun Pharmaceutical Group Co Ltd, which bought Ambrx Inc, a US biotechnology company focusing on molecular medicine.

The acquisition group also involved HOPU Jinghua (Beijing) Investment Consultancy Co Ltd, China Everbright Ltd's healthcare fund, and Wuxi PharmaTech, and the purchase included some valuable global biotechnology.

Fosun Pharma's Chairman Chen Qiyu said the acquisition would "produce a dramatic synergistic effect on Fosun's current development system".

Ambrx is now expected to build a global products development center in China, Chen said.

Other moves saw Chinese companies signing agreements with foreign companies to sell their products overseas.

Jiangsu Heng Rui Medicine Co Ltd, for instance, authorized US-based pharmaceutical company Incyte Corp to develop and sell its PD-1 antibody product outside China in September, with the Delaware firm paying $795 million for the right.

wangwen@chinadaily.com.cn

 

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产成人教育视频在线观看 | 97久久曰曰久久久 | 特黄毛片 | 免费一级毛片在线播放不收费 | 亚洲一区二区三区免费 | 乱子伦农村xxxx视频 | 欧美日本在线三级视频 | 欧美xxxx性xxxxx高清视频 | 欧美成本人视频 | 男女男精品视频网站在线观看 | 欧美综合视频在线观看 | 欧美成人香蕉网在线观看 | 久久国产夜色精品噜噜亚洲a | 欧美高清视频在线 | 制服丝袜在线视频香蕉 | 夜色www国产精品资源站 | 中文国产成人精品久久一区 | 九九热爱视频精品视频高清 | 欧美日韩精品免费一区二区三区 | 欧美性色xo影院在线观看 | 高清波多野结衣一区二区三区 | 荡女妇边被c边呻吟久久 | 亚洲国产精选 | 成年人网站在线观看视频 | 中文字幕在线视频在线看 | 欧美成人免费在线观看 | 国产日韩欧美自拍 | 91进入蜜桃臀在线播放 | 国产精品一区二区三区免费 | 大片国产片日本观看免费视频 | 欧美亚洲国产日韩一区二区三区 | 老司机黄色影院 | 亚洲影院手机版777点击进入影院 | 一级二级三级毛片 | 国产成人免费不卡在线观看 | 国产精品亚欧美一区二区三区 | 久久久网站| 办公室紧身裙丝袜av在线 | 免费观看女人一摸全是水 | 久久九九有精品国产56 | 免费看 s色|